当前位置: X-MOL 学术Lancet Infect Dis › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Addressing antimicrobial resistance in the UK and Europe
The Lancet Infectious Diseases ( IF 36.4 ) Pub Date : 2017-11-10 , DOI: 10.1016/s1473-3099(17)30633-3
Victoria Wells , Laura J V Piddock

Antimicrobial resistance (AMR) has received substantial attention in recent years. Since bacteria evolve to resist the effects of existing antibiotics, infections can become more difficult to treat and subsequently modern medical interventions can become more dangerous for patients. Fear of so-called superbugs has spurred international authorities into action. In 2011, WHO developed a European strategic action plan on antibiotic resistance,1 which set forth strategic objectives to aid European member states in addressing the complex factors that cause AMR.

中文翻译:

解决英国和欧洲的抗菌素耐药性

近年来,抗菌素耐药性(AMR)受到了广泛关注。由于细菌会发展为抵抗现有抗生素的作用,因此感染可能变得更加难以治疗,随后现代医学干预措施可能对患者造成更大的危险。对所谓的超级细菌的恐惧促使国际当局采取行动。2011年,世卫组织制定了一项关于抗生素耐药性的欧洲战略行动计划,1提出了战略目标,以帮助欧洲成员国解决引起AMR的复杂因素。
更新日期:2017-11-11
down
wechat
bug